BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28

• Bio NC

  HyperBranch Medical Technology, Inc. Completes Clinical Enrollment

  September 24, 2012

   · 

  1 min read
• Boston Scientific Corporation Launches New Implantable Defibrillation Lead In Europe And Asia

  September 24, 2012

   · 

  5 min read
• Pharm Country

  Vascular Insights Release: ClariVein® Announces Randomized Clinical Trial Comparing VNUS ClosureFAST With ClariVein for Varicose Vein

  September 24, 2012

   · 

  1 min read
• Pluristem Therapeutics Announces Closing of Underwriters’ Option to Purchase Additional Common Stock

  September 24, 2012

   · 

  1 min read
• Catalyst Pharmaceutical Partners, Inc. Announces Commencement of CPP-109 Investigator-Sponsored Study in Patients With Treatment Refractory Tourette’s Disorder

  September 24, 2012

   · 

  1 min read
• Business

  Zyomyx, Inc. Announces Appointment of Chief Financial Officer

  September 24, 2012

   · 

  1 min read
• Policy

  Spectrum Pharmaceuticals, Inc. Provides Update on Belinostat Registrational Trial for the Treatment of Relapsed/Refractory Peripheral T-Cell Lymphoma (PTCL)

  September 24, 2012

   · 

  1 min read
• Policy

  Hemispherx Biopharma Announces FDA Advisory Committee Will Review Ampligen® for Chronic Fatigue Syndrome

  September 24, 2012

   · 

  1 min read
• Drug Development

  RXi Pharmaceuticals Announces Completion of Dosing in Phase 1 Trial for RXI-109 Program

  September 24, 2012

   · 

  1 min read
• BioLineRx Ltd. Receives Notice of Allowance From USPTO for New Patent on BL-1020, Extending Patent Protection Until 2031

  September 24, 2012

   · 

  1 min read